Upregulation of p21(WAF1/Cip1) precedes tumor necrosis factor-induced necrosis-like cell death
Related Experiment Video
Updated: Aug 9, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Sandra Ussat1, Ulf-Eike Werner, Marie-Luise Kruse
1Institut für Immunologie, Christian-Albrechts-Universität Kiel, Michaelisstrasse 5, Kiel D-24105, Germany.
Abstract:
The molecular mechanisms mediating death receptor-induced caspase-independent necrotic cell death are still largely unknown. We have previously reported that NIH3T3 cells are sensitized by caspase inhibition to death receptor-induced cytotoxicity leading to a necrosis-like cell death. In addition, we have identified an important role of cell cycle progression for this sensitization effect. Here, we report that tumor necrosis factor-induced necrotic death is preceded by an upregulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1). Increased expression of p21(WAF1/Cip1) occurs prior to cell death in the nucleus, where it binds to a cyclin-dependent kinase indicating its functionality. The use of specific pharmacological inhibitors revealed a partial involvement of p38 mitogen-activated protein kinase in the upregulation of p21(WAF1/Cip1). Inhibition of p21(WAF1/Cip1) upregulation prevents a previously observed delay of the cells in the G2/M phase of the cell cycle thereby augmenting, not inhibiting cell death.
Insights
Tumor necrosis factor triggers necrotic cell death via p21(WAF1/Cip1) upregulation, a process influenced by cell cycle progression. Inhibiting p21(WAF1/Cip1) enhances this necrotic cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Caspase-independent necrotic cell death mechanisms are not fully understood.
- NIH3T3 cells show sensitization to death receptor-induced cytotoxicity with caspase inhibition, leading to necrosis-like cell death.
- Cell cycle progression plays a role in this sensitization effect.
Purpose of the Study:
- To investigate the molecular mechanisms of tumor necrosis factor-induced necrotic cell death.
- To elucidate the role of p21(WAF1/Cip1) and cell cycle progression in this process.
Main Methods:
- Upregulation of p21(WAF1/Cip1) was assessed in NIH3T3 cells treated with tumor necrosis factor.
- The functionality of p21(WAF1/Cip1) was examined through its nuclear localization and binding to cyclin-dependent kinases.
- Pharmacological inhibitors were used to explore the involvement of p38 mitogen-activated protein kinase.
- The effect of p21(WAF1/Cip1) inhibition on cell cycle progression and cell death was analyzed.
Main Results:
- Tumor necrosis factor-induced necrotic death is preceded by increased expression of p21(WAF1/Cip1).
- p21(WAF1/Cip1) upregulation occurs in the nucleus, indicating functional activity.
- p38 mitogen-activated protein kinase partially contributes to p21(WAF1/Cip1) upregulation.
- Inhibition of p21(WAF1/Cip1) upregulation prevents G2/M cell cycle delay and augments cell death.
Conclusions:
- p21(WAF1/Cip1) upregulation is a key event in tumor necrosis factor-induced necrotic cell death.
- The interplay between p21(WAF1/Cip1), cell cycle progression, and necrotic cell death is crucial.
- Targeting p21(WAF1/Cip1) may offer therapeutic strategies for enhancing necrotic cell death in cancer treatment.
Related Concept Videos
Abnormal Proliferation
Regulation of the Unfolded Protein Response
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...

